Medtronic plc — Director's Dealing 2016

Jun 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-06-03

Reporting Person: Kuntz Richard (SrVP & Chief Scien, Clin, Reg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-03	Ordinary Shares	M	23028	$47.77	Acquired	127647	Direct
2016-06-03	Ordinary Shares	M	35872	$36.24	Acquired	163519	Direct
2016-06-03	Ordinary Shares	S	49905	$82.60	Disposed	113614	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-03	Stock Option (Right to Buy)	$47.77	M	23028	Disposed	2017-10-29	Ordinary Shares (23028)	Direct
2016-06-03	Stock Option (Right to Buy)	$36.24	M	35872	Disposed	2018-10-27	Ordinary Shares (35872)	Direct

Footnotes

F1: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $82.42 to $82.865, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.

F2: This balance increased by 261 shares due to exempt transactions such as dividend reinvestment.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.